The Association Between Lactate Dehydrogenase to Serum Albumin Ratio and In-hospital Mortality in Patients with Pulmonary Embolism: a Retrospective Analysis of the MIMIC-IV Database

Overview

Journal Front Cardiovasc Med

Specialty Cardiology & Vascular Diseases

Date 2024 Jul 4

PMID 38962086

Authors

Jingjing Hu

Yidan Zhou

Affiliations

Soon will be listed here.

Abstract

Background: Lactate dehydrogenase (LDH) and albumin (ALB) were found to be significantly correlated with mortality in pulmonary embolism (PE) patients. However, data regarding the LDH/ALB ratio (LAR) in patients with acute PE are scanty. Therefore, the aim of this study was to investigate the association between LAR and the risk of mortality in patients with acute PE.

Methods: A retrospective cohort study was conducted on patients with acute PE represented in the Medical Information Mart for Intensive Care IV (MIMIC-IV). A receiver operating characteristic (ROC) curve analysis and calibration curve were used to assess the accuracy of the LAR for predicting mortality in patients with acute PE. We utilized Cox regression analysis to determine adjusted hazard ratios (HR) and 95% confidence interval (CI). Survival curves were used to evaluate a connection between the LAR and prognosis in patients with acute PE.

Results: The study comprised 581 patients, and the 30-day all-cause mortality rate was 7.7%. We observed a higher LAR in the non-survival group compared to the surviving group (21.24 ± 21.22 vs. 8.99 ± 7.86, < 0.0001). The Kaplan-Meier analysis showed that patients with an elevated LAR had a significantly lower likelihood of surviving the 30-day mortality compared to those with a low LAR. Cox regression analysis showed that LAR (HR = 1.04, 95% CI: 1.03-1.05) might have associations with 30-day mortality in patients with acute PE. This result was supported by sensitivity analyses. According to the results of the ROC curve analysis, the LAR's prediction of 30-day mortality in patients with acute PE yielded an area under the ROC curve of 0.73. A calibration curve showed LAR is well calibrated.

Conclusion: Our research suggests LAR monitoring may be promising as a prognostic marker among patients with acute PE.

Citing Articles

Assessing the Predictive Impact of Preoperative Lactate Dehydrogenase to Albumin Ratio on Outcomes Following Coronary Artery Bypass Graft Surgery.

Baris O, Holat C, Tosun M, Yaman U, Durmaz A, Canikoglu M J Clin Med. 2025; 14(2).

PMID: 39860556 PMC: 11765517. DOI: 10.3390/jcm14020554.

Pulmonary embolism in children with mycoplasma pneumonia: can it be predicted?.

Hou J, Sun R, Zhang X, Jia W, Li P, Song C Eur J Clin Microbiol Infect Dis. 2024; 44(2):393-403.

PMID: 39688754 DOI: 10.1007/s10096-024-05014-3.

Inflammatory and Metabolic Predictors of Mortality in Pulmonary Thromboembolism: A Focus on the Triglyceride-Glucose Index and Pan-Immune Inflammation Value.

Bilgin M, Akkaya E, Dokuyucu R J Clin Med. 2024; 13(19).

PMID: 39408068 PMC: 11477710. DOI: 10.3390/jcm13196008.

References

Chi G, Gibson C, Liu Y, Hernandez A, Hull R, Cohen A . Inverse relationship of serum albumin to the risk of venous thromboembolism among acutely ill hospitalized patients: Analysis from the APEX trial. Am J Hematol. 2018; 94(1):21-28. DOI: 10.1002/ajh.25296. View

Stabenow L, Zibrova D, Ender C, Helbing D, Spengler K, Marx C . Oxidative Glucose Metabolism Promotes Senescence in Vascular Endothelial Cells. Cells. 2022; 11(14). PMC: 9322806. DOI: 10.3390/cells11142213. View

Konigsbrugge O, Posch F, Riedl J, Reitter E, Zielinski C, Pabinger I . Association Between Decreased Serum Albumin With Risk of Venous Thromboembolism and Mortality in Cancer Patients. Oncologist. 2016; 21(2):252-7. PMC: 4746083. DOI: 10.1634/theoncologist.2015-0284. View

Jimenez D, de Miguel-Diez J, Guijarro R, Trujillo-Santos J, Otero R, Barba R . Trends in the Management and Outcomes of Acute Pulmonary Embolism: Analysis From the RIETE Registry. J Am Coll Cardiol. 2016; 67(2):162-170. DOI: 10.1016/j.jacc.2015.10.060. View

Wendelboe A, Raskob G . Global Burden of Thrombosis: Epidemiologic Aspects. Circ Res. 2016; 118(9):1340-7. DOI: 10.1161/CIRCRESAHA.115.306841. View

Saghazadeh A, Hafizi S, Rezaei N . Inflammation in venous thromboembolism: Cause or consequence?. Int Immunopharmacol. 2015; 28(1):655-65. DOI: 10.1016/j.intimp.2015.07.044. View

Edwards Y, Povey S, LeVan K, Driscoll C, Millan J, Goldberg E . Locus determining the human sperm-specific lactate dehydrogenase, LDHC, is syntenic with LDHA. Dev Genet. 1987; 8(4):219-32. DOI: 10.1002/dvg.1020080406. View

Mikhailidis D, Ganotakis E . Plasma albumin and platelet function: relevance to atherogenesis and thrombosis. Platelets. 2010; 7(3):125-37. DOI: 10.3109/09537109609023571. View

Franczyk B, Gluba-Brzozka A, Lawinski J, Rysz-Gorzynska M, Rysz J . Metabolomic Profile in Venous Thromboembolism (VTE). Metabolites. 2021; 11(8). PMC: 8400436. DOI: 10.3390/metabo11080495. View

10.

Kunutsor S, Seidu S, Katechia D, Laukkanen J . Inverse association between serum albumin and future risk of venous thromboembolism: interrelationship with high sensitivity C-reactive protein. Ann Med. 2018; 50(3):240-248. DOI: 10.1080/07853890.2018.1441537. View

11.

Fanali G, Di Masi A, Trezza V, Marino M, Fasano M, Ascenzi P . Human serum albumin: from bench to bedside. Mol Aspects Med. 2012; 33(3):209-90. DOI: 10.1016/j.mam.2011.12.002. View

12.

Shao H, Li S . A new perspective on HIV: effects of HIV on brain-heart axis. Front Cardiovasc Med. 2023; 10:1226782. PMC: 10436320. DOI: 10.3389/fcvm.2023.1226782. View

13.

Doherty S . Pulmonary embolism An update. Aust Fam Physician. 2017; 46(11):816-820. View

14.

Sogaard K, Schmidt M, Pedersen L, Horvath-Puho E, Sorensen H . 30-year mortality after venous thromboembolism: a population-based cohort study. Circulation. 2014; 130(10):829-36. DOI: 10.1161/CIRCULATIONAHA.114.009107. View

15.

Ding K, Wang H, Jia Y, Zhao Y, Yang W, Chen W . Incidence and risk factors associated with preoperative deep venous thrombosis in the young and middle-aged patients after hip fracture. J Orthop Surg Res. 2022; 17(1):15. PMC: 8753898. DOI: 10.1186/s13018-021-02902-8. View

16.

Joorgensen K, Stoffersen E . Heparin like activity of albumin. Thromb Res. 1979; 16(3-4):569-74. DOI: 10.1016/0049-3848(79)90105-1. View

17.

Engelmann B, Massberg S . Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol. 2012; 13(1):34-45. DOI: 10.1038/nri3345. View

18.

Jellinge M, Henriksen D, Hallas P, Brabrand M . Hypoalbuminemia is a strong predictor of 30-day all-cause mortality in acutely admitted medical patients: a prospective, observational, cohort study. PLoS One. 2014; 9(8):e105983. PMC: 4141840. DOI: 10.1371/journal.pone.0105983. View

19.

Garcia-Martinez R, Caraceni P, Bernardi M, Gines P, Arroyo V, Jalan R . Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications. Hepatology. 2013; 58(5):1836-46. DOI: 10.1002/hep.26338. View

20.

Bagot C, Arya R . Virchow and his triad: a question of attribution. Br J Haematol. 2008; 143(2):180-90. DOI: 10.1111/j.1365-2141.2008.07323.x. View